Russell Frank Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Russell Frank Company’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.4M	Sell	486,440 -322,720	-40%	-$2.88M	0.01%	1422
2015 Q4	$7.49M	Buy	809,160 +63,790	+9%	+$699K	0.01%	1043
2015 Q3	$9.47M	Sell	745,370 -96,965	-12%	-$1.2M	0.02%	922
2015 Q2	$9.29M	Buy	842,335 +3,495	+0.4%	+$38.6K	0.01%	1042
2015 Q1	$9.58M	Sell	838,840 -331,695	-28%	-$3.52M	0.02%	891
2014 Q4	$11.7M	Buy	1,170,535 +129,370	+12%	+$1.36M	0.02%	825
2014 Q3	$10.9M	Sell	1,041,165 -38,240	-4%	-$359K	0.02%	853
2014 Q2	$9.66M	Buy	1,079,405 +540,655	+100%	+$4.55M	0.02%	944
2014 Q1	$4.73M	Buy	538,750 +219,750	+69%	+$1.91M	0.01%	1333
2013 Q4	$2.61M	Sell	319,000 -76,690	-19%	-$607K	﹤0.01%	1575
2013 Q3	$2.99M	Buy	395,690 +2,690	+0.7%	+$19.6K	0.01%	1639
2013 Q2	$2.97M	Buy	+393,000	New	+$2.87M	0.01%	1548

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Russell Frank Company's RDY Position: Q1 2016 in Review

Russell Frank Company reduced its Dr. Reddy's Laboratories (RDY) stake by 40% in Q1 2016, selling an estimated $2.88M and leaving 486,440 shares worth $4.4M. The position accounts for 0.01% of the portfolio, ranked #1422.

Russell Frank Company first reported a position in RDY in Q2 2013 and has held it in 12 quarters since. The position peaked at $11.7M in Q4 2014. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

Russell Frank Company held 486,440 shares of Dr. Reddy's Laboratories worth $4.4M as of Q1 2016.
Russell Frank Company sold 322,720 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $2.88M.
Dr. Reddy's Laboratories made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1422 holding.
Russell Frank Company first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Dr. Reddy's Laboratories position peaked at $11.7M in Q4 2014.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.